Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Chris Lange | Jul 11, 2017 at 12:10 PM EDT

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's…

Chris Lange | Jun 27, 2017 at 8:50 AM EDT

Major Biotech Short Interest Surges

The June 15 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Jun 23, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences…

Chris Lange | Jun 12, 2017 at 11:25 AM EDT

Why Coherus Biosciences Shares Are Crashing

Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from…

Chris Lange | Jun 12, 2017 at 9:40 AM EDT

Short Interest Surges in Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | May 25, 2017 at 9:50 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | May 10, 2017 at 10:40 AM EDT

Major Biotech Short Interest Remains Mixed

The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | Apr 26, 2017 at 9:40 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | Apr 25, 2017 at 12:45 PM EDT

Boeing, P&G and 5 More Key Earnings Reports Coming Wednesday

24/7 Wall St. has put together a preview of Boeing, PepsiCo and other top companies scheduled to report their quarterly…

Chris Lange | Apr 12, 2017 at 9:10 AM EDT

Short Sellers Back Off Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 10:30 AM EDT

Short Interest Pulls Back in Major Biotechs

The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of…

Chris Lange | Mar 10, 2017 at 10:30 AM EST

Major Biotechs See a Retreat in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest decreased in most of…

Jon C. Ogg | Mar 9, 2017 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.

Chris Lange | Feb 28, 2017 at 10:15 AM EST

Short Sellers Hike Their Bets in Major Biotechs

The February 15 short interest data have been compared with the previous report, and short interest increased in all the…

Lee Jackson | Feb 23, 2017 at 8:15 AM EST

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is…

1 … 18 19 20 21 22 … 47

Amgen : AMGN

All Amgen Articles

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Major Biotech Short Interest Surges

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Why Coherus Biosciences Shares Are Crashing

Short Interest Surges in Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Major Biotech Short Interest Remains Mixed

Short Sellers Grow More Selective on Major Biotechs

Boeing, P&G and 5 More Key Earnings Reports Coming Wednesday

Short Sellers Back Off Major Biotechs

Short Interest Pulls Back in Major Biotechs

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Short Sellers Hike Their Bets in Major Biotechs

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Major Biotech Short Interest Surges

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Why Coherus Biosciences Shares Are Crashing

Short Interest Surges in Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Major Biotech Short Interest Remains Mixed

Short Sellers Grow More Selective on Major Biotechs

Boeing, P&G and 5 More Key Earnings Reports Coming Wednesday

Short Sellers Back Off Major Biotechs

Short Interest Pulls Back in Major Biotechs

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Short Sellers Hike Their Bets in Major Biotechs

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%